An Open-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast Growth Factor 21 in Patients with Nonalcoholic Fatty Liver Disease

<div>The plot of Pearson correlation of FGF 21 change with the changes in waist circumference, waist-to-hip ratio, controlled attenuation parameters, and gamma-glutamyl transferasec in polyene phosphatidylcholine group.</div>

Evidence-Based Complementary and Alternative Medicine

fig5

Figure 5

Figure 5: An Open-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast Growth Factor 21 in Patients with Nonalcoholic Fatty Liver Disease 

Figure 5 | An Open-Label Exploratory Clinical Trial Evaluating the Effects of GLS (Coptidis Rhizoma-Evodiae Fructus 2 : 1) on Fibroblast Growth Factor 21 in Patients with Nonalcoholic Fatty Liver Disease 